BIOA-B BioArctic AB (publ)
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden. It engages in the research and development of biological drugs, such as antibodies that address high unmet medic…
Industry Peers
Biotechnology| Headline | Source | Time |
|---|---|---|
Older | ||
BioArctic AB (BRCTF) (Q2 2026) Earnings Call Highlights: FDA Approval of Leqembi Autoinjector ... BioArctic AB (BRCTF) reports strong royalty growth and strategic partnerships, positioning for a transformative year ahead. | ||
 Eli Lilly (LLY) Adds Alzheimer’s Research Deal As Obesity Cost Data Builds Eli Lilly (NYSE:LLY) agreed a new research and collaboration deal with BioArctic that applies BioArctic's BrainTransporter technology to a potential Alzheimer's treatment. The BioArctic agreement expands Eli Lilly's drug development activity in neurodegenerative disease beyond its existing diabetes and obesity portfolio. New real-world data report that adults over 55 with obesity who stay on Zepbound for longer periods record lower healthcare costs than those who do not. The Zepbound... | ||
TTradeVenue | ||
FFinanstid | ||